Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcript
· fool.com · popularity 28/100 · 2 similar stories today
Read the original at fool.com →
Summary
Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins. Image source: The Motley Fool. Nov. 2, 2026 CALL …
Found in: The Motley Fool. Rating basis: 2 other outlets; outlet tier 2 (unlisted); 1 feeds; feed position 10.